Access Statistics for Anirban Basu

Author contact details at EconPapers.

Working Paper File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
Comparing 2SLS vs 2SRI for Binary Outcomes and Binary Exposures 0 0 1 46 0 0 3 80
Economics of Individualization in Comparative Effectiveness Research and a Basis for a Patient-Centered Health Care 0 0 2 47 0 0 8 174
Estimating Lifetime or Episode-of-illness Costs 0 1 2 107 0 1 6 282
Estimating Person-Centered Treatment (PeT) Effects Using Instrumental Variables 0 0 0 52 0 0 0 153
Exploring comparative effect heterogeneity with instrumental variables: prehospital intubation and mortality 0 0 0 18 0 0 0 97
Exploring comparative effect heterogeneity with instrumental variables: prehospital intubation and mortality 1 1 1 39 1 1 23 182
Generalized Modeling Approaches to Risk Adjustment of Skewed Outcomes Data 0 0 0 43 0 0 1 156
Generalized Modeling Approaches to Risk Adjustment of Skewed Outcomes Data 0 0 0 290 0 0 2 870
Hidden Figures: Uncovering Quantities Behind Zeros with Econometrics 0 0 15 15 0 1 19 19
Impact of Rural and Urban Hospital Closures on Inpatient Mortality 0 0 1 83 0 3 11 142
Political Polarization, Anticipated Health Insurance Uptake and Individual Mandate: A view from the Washington State 0 0 0 16 0 0 0 37
Price Elasticities of Pharmaceuticals in a Value-Based-Formulary Setting 0 0 2 61 0 1 4 90
Returns to Pharmaceutical Innovation in the Market for Oral Chemotherapy in Response to Insurance Coverage Expansion 0 0 0 50 0 0 1 33
Service-level Selection: Strategic Risk Selection in Medicare Advantage in Response to Risk Adjustment 0 0 0 7 0 0 0 49
The Impact of Comparative Effectiveness Research on Health and Health Care Spending 0 0 0 57 0 0 0 228
The New Prescription Drug Paradox: Pipeline Pressure and Rising Prices 0 0 1 73 1 2 9 99
The Roles of Cognitive and Non-Cognitive Skills in Moderating the Effects of Mixed-Ability Schools on Long-Term Health 0 0 0 42 0 0 2 100
The impact of Medicare Part D on Medicare-Medicaid Dual-eligible Beneficiaries' Prescription Utilization and Expenditures 0 0 0 42 0 0 0 157
Understanding Algorithmic Discrimination in Health Economics Through the Lens of Measurement Errors 0 0 1 21 0 0 2 47
Use of Propensity Scores in Non-Linear Response Models: The Case for Health Care Expenditures 0 0 0 53 0 0 2 215
Use of instrumental variables in the presence of heterogeneity and self-selection: An application in breast cancer patients 0 0 0 481 1 2 2 1,335
Use of propensity scores in non-linear response models: The case for health care expenditures 0 0 0 146 0 3 13 513
Welfare Implications of Learning Through Solicitation versus Diversification in Health Care 0 0 0 36 0 0 1 55
Total Working Papers 1 2 26 1,825 3 14 109 5,113


Journal Article File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
CAN WE MAKE SMART CHOICES BETWEEN OLS AND CONTAMINATED IV METHODS? 0 0 1 3 0 0 1 23
Comparing alternative models: log vs Cox proportional hazard? 0 0 2 146 0 0 2 566
Does Competition under Medicare Prospective Payment Selectively Reduce Expenditures on High-Cost Patients? 0 0 0 0 0 0 0 313
ESTIMATING PERSON‐CENTERED TREATMENT (PeT) EFFECTS USING INSTRUMENTAL VARIABLES: AN APPLICATION TO EVALUATING PROSTATE CANCER TREATMENTS 0 0 0 6 0 0 0 38
Economics of individualization in comparative effectiveness research and a basis for a patient-centered health care 0 0 0 29 0 1 13 241
Erratum: Estimating lifetime or episode‐of‐illness costs under censoring 0 0 0 15 0 0 0 46
Estimating lifetime or episode‐of‐illness costs under censoring 0 1 3 20 0 1 5 77
Extended generalized linear models: Simultaneous estimation of flexible link and variance functions 0 1 2 143 0 2 5 413
Generalized modeling approaches to risk adjustment of skewed outcomes data 0 0 1 140 0 0 5 353
HETEROGENEITY IN ACTION: THE ROLE OF PASSIVE PERSONALIZATION IN COMPARATIVE EFFECTIVENESS RESEARCH 0 0 0 2 0 0 1 24
HIGHLIGHTING DIFFERENCES BETWEEN CONDITIONAL AND UNCONDITIONAL QUANTILE REGRESSION APPROACHES THROUGH AN APPLICATION TO ASSESS MEDICATION ADHERENCE 0 0 2 100 0 3 9 278
Implications of spillover effects within the family for medical cost-effectiveness analysis 0 0 2 72 0 1 4 180
Measuring the Value of Pharmaceuticals in the US Health System 0 0 0 5 0 0 0 14
Person-centered treatment (PeT) effects: Individualized treatment effects using instrumental variables 0 0 2 34 0 0 5 133
Personalized Medicine in the Context of Comparative Effectiveness Research 0 0 0 13 0 1 1 101
Private Manufacturers’ Thresholds to Invest in Comparative Effectiveness Trials 0 0 0 5 0 0 0 47
RESPONSE TO EPSTEIN'S COMMENT ON “HETEROGENEITY IN ACTION” 0 0 0 1 0 0 0 17
Scale of interest versus scale of estimation: comparing alternative estimators for the incremental costs of a comorbidity 0 0 0 52 0 1 2 217
The impact of comparative effectiveness research on health and health care spending 0 1 1 35 0 2 4 273
Two-stage residual inclusion estimation: Addressing endogeneity in health econometric modeling 0 0 2 914 0 1 17 2,671
Welfare implications of learning through solicitation versus diversification in health care 0 0 0 2 0 0 0 34
Total Journal Articles 0 3 18 1,737 0 13 74 6,059


Software Item File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
IVCHECK: Stata module to choose between OLS and contaminated IV 0 0 0 24 0 0 3 216
Total Software Items 0 0 0 24 0 0 3 216


Statistics updated 2024-02-04